Lobe Sciences (XCNQ:LOBE) Long-Term Debt : C$1.11 Mil (As of Aug. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences Long-Term Debt?

Lobe Sciences's Long-Term Debt for the quarter that ended in Aug. 2024 was C$1.11 Mil.

Lobe Sciences's quarterly Long-Term Debt increased from Feb. 2024 (C$0.00 Mil) to May. 2024 (C$1.93 Mil) but then declined from May. 2024 (C$1.93 Mil) to Aug. 2024 (C$1.11 Mil).

Lobe Sciences's annual Long-Term Debt stayed the same from Aug. 2022 (C$0.00 Mil) to Aug. 2023 (C$0.00 Mil) but then increased from Aug. 2023 (C$0.00 Mil) to Aug. 2024 (C$1.11 Mil).

Lobe Sciences Long-Term Debt Historical Data

The historical data trend for Lobe Sciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences Long-Term Debt Chart

Lobe Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Long-Term Debt

Get a 7-Day Free Trial

1.11

Lobe Sciences Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Long-Term Debt	Get a 7-Day Free Trial															-	-	-	1.93	1.11

Lobe Sciences (XCNQ:LOBE) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Lobe Sciences Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

LOBEF:USA 6YX0:Germany

Address

1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5

Website

https://www.lobesciences.com

Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.

Lobe Sciences Headlines

No Headlines